Alvotech Stock Fundamentals
| ALVO Stock | USD 11.99 0.45 3.62% |
Alvotech fundamentals help investors to digest information that contributes to Alvotech's financial success or failures. It also enables traders to predict the movement of Alvotech Stock. The fundamental analysis module provides a way to measure Alvotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alvotech stock.
At this time, Alvotech's Interest Income is very stable compared to the past year. As of the 25th of November 2024, Interest Expense is likely to grow to about 139.4 M, though Tax Provision is likely to grow to (94.4 M). Alvotech | Select Account or Indicator |
Alvotech Company Shares Outstanding Analysis
Alvotech's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Alvotech Shares Outstanding | 301.94 M |
Most of Alvotech's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alvotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Alvotech Shares Outstanding Historical Pattern
Today, most investors in Alvotech Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alvotech's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Alvotech shares outstanding as a starting point in their analysis.
Alvotech Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Alvotech Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Alvotech has 301.94 M of shares currently outstending. This is 67.25% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 47.2% higher than that of the company.
Alvotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alvotech's current stock value. Our valuation model uses many indicators to compare Alvotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alvotech competition to find correlations between indicators driving Alvotech's intrinsic value. More Info.Alvotech is rated below average in return on asset category among its peers. It is rated below average in profit margin category among its peers . At this time, Alvotech's Net Loss is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alvotech's earnings, one of the primary drivers of an investment's value.Alvotech Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alvotech's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alvotech could also be used in its relative valuation, which is a method of valuing Alvotech by comparing valuation metrics of similar companies.Alvotech is currently under evaluation in shares outstanding category among its peers.
Alvotech ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alvotech's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alvotech's managers, analysts, and investors.Environmental | Governance | Social |
Alvotech Fundamentals
| Return On Asset | -0.0761 | ||||
| Profit Margin | (2.00) % | ||||
| Operating Margin | 0.46 % | ||||
| Current Valuation | 4.68 B | ||||
| Shares Outstanding | 301.94 M | ||||
| Shares Owned By Insiders | 64.01 % | ||||
| Shares Owned By Institutions | 6.03 % | ||||
| Number Of Shares Shorted | 79.01 K | ||||
| Price To Sales | 11.73 X | ||||
| Revenue | 91.43 M | ||||
| Gross Profit | 20.92 M | ||||
| EBITDA | (484.86 M) | ||||
| Net Income | (551.73 M) | ||||
| Cash And Equivalents | 128.44 M | ||||
| Cash Per Share | 0.52 X | ||||
| Total Debt | 1.08 B | ||||
| Current Ratio | 0.86 X | ||||
| Book Value Per Share | (3.50) X | ||||
| Cash Flow From Operations | (312.19 M) | ||||
| Short Ratio | 0.58 X | ||||
| Earnings Per Share | (1.85) X | ||||
| Target Price | 17.4 | ||||
| Number Of Employees | 999 | ||||
| Beta | -0.097 | ||||
| Market Capitalization | 3.62 B | ||||
| Total Asset | 950.09 M | ||||
| Retained Earnings | (2.21 B) | ||||
| Working Capital | (66.11 M) | ||||
| Net Asset | 950.09 M |
About Alvotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alvotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alvotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alvotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 59.2 M | 38.5 M | |
| Total Revenue | 91.4 M | 68.1 M | |
| Cost Of Revenue | 160.9 M | 168.9 M | |
| Stock Based Compensation To Revenue | 0.20 | 0.37 | |
| Sales General And Administrative To Revenue | 0.84 | 0.80 | |
| Research And Ddevelopement To Revenue | 2.31 | 3.28 | |
| Capex To Revenue | 0.51 | 0.42 | |
| Revenue Per Share | 0.40 | 0.38 | |
| Ebit Per Revenue | (3.88) | (4.08) |
Check out Alvotech Piotroski F Score and Alvotech Altman Z Score analysis. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.70) | Earnings Share (1.85) | Revenue Per Share 1.283 | Quarterly Revenue Growth 43.997 | Return On Assets (0.08) |
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.